Navigation Links
Stryker Hip Recall Update: FDA Announces Launch of New Medical Device Identification System to Better Target Recalls, Improve Patient Safety
Date:9/29/2013

ained pain, swelling, metallosis and other hip failure complications after receiving the Rejuvenate and/or ABG II modular-neck hip stems.

Stryker Hip Recall

Court documents issued in September indicate that Stryker lawsuits are continuing to pile up in both the federal and state proceedings established in the U.S. In a multicounty litigation currently underway in New Jersey’s Bergen County Superior Court, a total of 382 cases alleging injuries caused by the Stryker hip recall have been filed. The lawyers at Bernstein Liebhard LLP are actively filing cases alleging metallosis, necrosis, osteolysis and other artificial hip injuries in this litigation. (In Re Stryker Rejuvenate Hip Stem and the ABG II Modular Hip Stem Litigation, No. 296)

A total of 290 Stryker lawsuits are also pending in a federal proceeding underway in the U.S. District Court, District of Minnesota, which similarly allege that the Stryker Rejuvenate and ABG II hip stems were defectively designed by Stryker Orthopaedics, given the potential for their metal components to fret and corrode at the modular-neck junction. The next status conference in this litigation has been scheduled for November 21st at 9:00 a.m. (In re: Stryker Rejuvenate and ABG II Hip Implant Products Liability Litigation, MDL No. 2441)
Plaintiffs involved in in both of these proceedings were allegedly forced to undergo revision surgery to remove the metal hip after it failed prematurely.

The Stryker hip recall was announced by the manufacturer on July 6, 2012 after post-market surveillance data revealed the potential for the metal components of the Stryker Rejuvenate and ABG II hip stems to fail early. In the wake of the recall, Stryker Orthopaedics has advised all recipients of these devices to undergo routine medical screening to monitor for the high metal levels in the blood, whether or not they are experiencing symptoms.**

Individuals who may have sustained early hip failure com
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Olympus, Ethicon, Stryker and Karl Storz Lead the Growing Canadian Endoscopic and Surgical Device Market Valued at Nearly $500 Million, Reports iData Research
2. Stryker Hip Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Conference in New Jersey Stryker Hip Recall Litigation
3. Stryker Hip Lawsuits Continue to Mount as Claims in New Jersey Stryker Hip Recall Litigation Approach 400, Bernstein Liebhard LLP Reports
4. Michigan-Based Stryker Corp. and Its Howmedica Osteonics Subsidiary Are Targeted in Defective Hip Implant Lawsuit
5. Stryker Hip Implant News: Rottenstein Law Group LLP Applauds Consumer Reports’ Call for Metal-on-Metal Hip Manufacturer Accountability
6. Stryker Hip Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Conferences in State, Federal Stryker Hip Recall Litigations
7. The FDA Issues Class 1 Recall for Stryker’s Oasys Midline Occiput Plate Due to a Key Defect, Reports Parker Waichman LLP
8. Stryker Hip Lawsuit News: Wright & Schulte LLC Commend Mediation Plan in New Jersey Stryker Hip Replacement Lawsuits
9. Stryker Hip Lawsuit Update: Bernstein Liebhard LLP Notes Additional Progress in Stryker Hip Recall Litigation Underway in New Jersey Superior Court
10. Stryker Hip Replacement Recall Lawyers at Wright & Schulte LLC Report on Growing Number of Stryker Hip Replacement Lawsuits
11. Stryker Hip Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Case Management Order in New Jersey Stryker Recall Litigation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... May 06, 2015 More and more people ... created by Brian Flatt, personal trainer and nutritionist. This particular ... 23 pounds in just three weeks or 21 days. , ... been scientifically tested and found to work on all types ... On average, people lose between 12 and 23 pounds using ...
(Date:5/5/2015)... VA (PRWEB) May 06, 2015 Social ... Regulations, Make Social Media Your Most Powerful Marketing Tool ... – Washington, DC, http://www.fdanews.com/SocialMedia , Social media ... dream of social media’s reach. Patients are using it ... their doctors about what they’ve discovered. , But, it ...
(Date:5/5/2015)... 2015 The Journal of ... “ Priority interventions to improve the management of ... research of the ACCORD program ” , As ... actors, including clinicians, patients and family members, managers, ... which included knowledge gap, “work in silos”, lack ...
(Date:5/5/2015)... FL (PRWEB) May 05, 2015 ... company focused on the $1.6 billion peripheral nerve repair ... first quarter ended March 31, 2015 compared to $3.14 ... market’s continued adoption of our proprietary portfolio of nerve ... Connector and AxoGuard® Nerve Protector – and our solid ...
(Date:5/5/2015)... May 05, 2015 The 2015 Crystal Ball, ... to benefit their global research, outreach and patient advocacy programs. ... and awards ceremony that attracted hundreds of supporters. , The ... discovery of the hepatitis B virus (HBV) by Dr. Baruch ... the Nobel Prize in Medicine for his discovery of the ...
Breaking Medicine News(10 mins):Health News:Brian Flatt Announces The 3 Week Diet - A Scientifically Proven Diet Plan 2Health News:FDAnews Announces: Social Media Regulatory Affairs Summit, June 24-26, 2015 2Health News:FDAnews Announces: Social Media Regulatory Affairs Summit, June 24-26, 2015 3Health News:FDAnews Announces: Social Media Regulatory Affairs Summit, June 24-26, 2015 4Health News:Priority interventions in chronic non-cancer pain published by Dove Medical Press 2Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 2Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 3Health News:AxoGen, Inc. Reports 58% Year-Over-Year Revenue Growth for the 2015 First Quarter 4Health News:Hepatitis B Foundation Marks 50th Anniversary of HBV Discovery at its Crystal Ball Gala 2Health News:Hepatitis B Foundation Marks 50th Anniversary of HBV Discovery at its Crystal Ball Gala 3
... More than 600 people will gather for the Consortium ... held at the University of Washington in Seattle on ... in global health. The conference is the largest university-based ... all of the major university-based global health programs in ...
... journal Nature , Miguel Godinho Ferreira, Principal Investigator ... lead a team of researchers to shed light on ... of telomeres, the protective tips of chromosomes: while broken ... or cigarette smoke) are quickly joined together, telomeres are ...
... commonly prescribed to treat adolescent acne can increase attention ... fragile X syndrome, the most common inherited cause of ... is the first published on parents, reports of their ... by researchers at the UC Davis MIND Institute, the ...
... By Ellin Holohan HealthDay Reporter , WEDNESDAY, Sept. ... notion that angioplasty, a common procedure to open clogged arteries, ... a new study shows. In fact, the evidence suggests ... heart patients -- people whose condition has not changed recently ...
... fabrics to keep clothing looking fresh and wrinkle-free is unlikely ... article in the current issue of Chemical & Engineering News ... J. Hanson notes that manufacturers have added formaldehyde to fabrics ... care for, particularly to reduce wrinkling in cotton and prevent ...
... team representing the schools of Medicine, Nursing and Social ... clinical pastoral education programs in three Louisville hospitals, has ... Institutes of Health that will fund the development, implementation ... program. Work related to the project will begin immediately. ...
Cached Medicine News:Health News:University, government and philanthropic leaders converge in Seattle to advance global health 2Health News:University, government and philanthropic leaders converge in Seattle to advance global health 3Health News:Why chromosomes never tie their shoelaces 2Health News:Why chromosomes never tie their shoelaces 3Health News:Parents report a widely prescribed antibiotic is effective for fragile X treatment 2Health News:Parents report a widely prescribed antibiotic is effective for fragile X treatment 3Health News:Parents report a widely prescribed antibiotic is effective for fragile X treatment 4Health News:Many Heart Patients Place False Hope in Angioplasty 2Health News:Many Heart Patients Place False Hope in Angioplasty 3Health News:Grant will aid creation of interdisciplinary oncology palliative care education program 2Health News:Grant will aid creation of interdisciplinary oncology palliative care education program 3
(Date:5/5/2015)... BRIDGEWATER, N.J. , May 5, 2015  CorMedix ... developing and commercializing therapeutic products for the treatment of ... 2015 financial results on May 7.  Randy Milby ... investor conference call on Friday, May 8 at 9:00 ... in the conference call, please call 1-877-407-8031 (U.S.), 1-201-689-8031 ...
(Date:5/5/2015)... 5, 2015   InspireMD, Inc. (NYSE MKT: NSPR) ... announced today that it will release its full financial results ... May 11 th before the open, followed by a ... results and business outlook. Participants should call (888) ... (International) and request the InspireMD call. A live webcast of ...
(Date:5/5/2015)... May 5, 2015 GW Pharmaceuticals plc ... a biopharmaceutical company focused on discovering, developing and ... platform, announced today the closing of the previously ... GW of 1,600,000 American Depositary Shares (ADSs) at ... proceeds of approximately $179.2 million (before deducting underwriting ...
Breaking Medicine Technology:CorMedix, Inc. to Report First Quarter Financial Results on May 8, 2015 2InspireMD to Report Financial Results for the First Quarter Ended March 31, 2015 on Monday, May 11th 2InspireMD to Report Financial Results for the First Quarter Ended March 31, 2015 on Monday, May 11th 3GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 2GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 3GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 4
... Oct. 1 VirtualScopics, Inc. (Nasdaq: VSCP ), ... revenues for the third quarter ended September 30, 2010 exceeded ... comparable period in 2009 and a greater than 9% growth ... increased over 30% for the period ended September 30, 2010 ...
... 1 Palatin Technologies, Inc. (NYSE Amex: PTN ... Annual BIO Investor Forum on Wednesday, October 6, 2010 at ... the 9th Annual BIO Investor Forum will take place October ... Carl Spana, Ph.D., President and Chief Executive Officer ...
Cached Medicine Technology:VirtualScopics Revenues Hit Another Quarterly Record 2VirtualScopics Revenues Hit Another Quarterly Record 3
Inquire...
Inquire...
... Tura, the new Lulu Guinness Eyewear line ... retro Lulu Guinness herself. This collection brings ... the past with a flair for contemporary ... flair include a sizable collection of prescription ...
... a variety of colors and classic ... styles designed with elegant jewel detail. ... women that are made from the ... in our fine timepieces, Timex branded ...
Medicine Products: